Laguna P - Search Results

1

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B.

Serban M, Skotnicki AB, Colovic M, Jinca C, Klukowska A, Laguna P, Wolf DM. Serban M, et al. Among authors: laguna p. Haemophilia. 2012 Mar;18(2):175-81. doi: 10.1111/j.1365-2516.2011.02624.x. Epub 2011 Aug 3. Haemophilia. 2012. PMID: 21812863

2

Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia.

Klukowska A, Czyrny Z, Laguna P, Brzewski M, Serafin-Krol MA, Rokicka-Milewska R. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2001 May;7(3):286-92. doi: 10.1046/j.1365-2516.2001.00509.x. Haemophilia. 2001. PMID: 11380633

3

Acquired factor VIII inhibitor in a non-haemophilic boy.

Klukowska A, Łaguna P, Obitko-Płudowska A, Niedzielska K, Malinowska I, Rokicka-Milewska R. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2003 Sep;9(5):642-5. doi: 10.1046/j.1365-2516.2003.00797.x. Haemophilia. 2003. PMID: 14511308

4

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia A.

Wolf DM, Rokicka-Milewska R, Lopaciuk S, Skotnicki AB, Klukowska A, Laguna P, Windyga J, Kotitschke R, Struff WG. Wolf DM, et al. Among authors: laguna p. Haemophilia. 2004 Sep;10(5):438-48. doi: 10.1111/j.1365-2516.2004.00947.x. Haemophilia. 2004. PMID: 15357768 Clinical Trial.

5

Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.

Laguna P, Klukowska A. Laguna P, et al. Haemophilia. 2005 Jan;11(1):2-4. doi: 10.1111/j.1365-2516.2005.01051.x. Haemophilia. 2005. PMID: 15660981 Review.

6

Intracranial haemorrhage in a boy with severe haemophilia A and factor VIII inhibitor.

Laguna P, Klukowska A. Laguna P, et al. Childs Nerv Syst. 2006 Apr;22(4):432-5. doi: 10.1007/s00381-005-1168-7. Epub 2005 Jun 1. Childs Nerv Syst. 2006. PMID: 15928966

7

Efficacy and safety of OCTANINE F in children with haemophilia B.

Klukowska A, Laguna P, Svirin P, Shiller E, Vdovin V. Klukowska A, et al. Among authors: laguna p. Haemophilia. 2008 May;14(3):531-8. doi: 10.1111/j.1365-2516.2008.01678.x. Epub 2008 Mar 18. Haemophilia. 2008. PMID: 18355266 Clinical Trial.

8

Factor IX pharmacokinetics: differences between plasma-derived and recombinant products and the clinical and economic implications: a meeting report.

Morfini M, Laguna P, Leissinger C. Morfini M, et al. Among authors: laguna p. Haemophilia. 2008 Jul;14(4):873-5. doi: 10.1111/j.1365-2516.2008.01762.x. Epub 2008 May 23. Haemophilia. 2008. PMID: 18510568 No abstract available.

9

Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.

Pan-Petesch B, Laguna P, Mital A, Stanley J, Torchet MF, Salek SZ, Salaj P. Pan-Petesch B, et al. Among authors: laguna p. Haemophilia. 2009 May;15(3):760-5. doi: 10.1111/j.1365-2516.2008.01968.x. Epub 2009 Feb 27. Haemophilia. 2009. PMID: 19298382

10

[Procedures for CV catheters insertion in children with congenital coagulation disorders].

Klukowska A, Łaguna P, Rawicz M. Klukowska A, et al. Among authors: laguna p. Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1126-9. Med Wieku Rozwoj. 2008. PMID: 19531837 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters